|
|
替奈普酶与阿替普酶静脉溶栓联合强化阿托伐他汀治疗急性缺血性脑卒中的临床疗效对比研究
|
Abstract:
目的：比较替奈普酶与阿替普酶静脉溶栓后分别联用强化阿托伐他汀方案治疗急性缺血性脑卒中的临床疗效及安全性差异。方法：采用平行对照设计，以本院急诊内科99例AIS患者为研究对象，替奈普酶组49例，阿替普酶组50例，分别予以替奈普酶、阿替普酶联合强化阿托伐他汀钙治疗。比较两组一般临床资料、美国国立卫生研究院卒中量表评分、改良Rankin量表评分、溶栓后出血不良事件、血脂指标。结果：与阿替普酶组相比，替奈普酶组治疗后NIHSS评分和90 d mRS评分降低更多，口腔粘膜出血发生率更低。结论：与阿替普酶相比，替奈普酶联合阿托伐他汀钙治疗急性缺血性脑卒中患者临床疗效更好，且安全性更高。
Objective: To compare the clinical efficacy and safety differences between teneplase and alteplase intravenous thrombolysis followed by an intensive atorvastatin regimen in combination with teneplase and alteplase, respectively, for the treatment of acute ischemic stroke. Methods: Using a parallel control design, 99 patients with AIS in the Department of Emergency Medicine of our hospital, 49 in the teneplase group and 50 in the alteplase group, were treated with teneplase and alteplase combined with intensive atorvastatin calcium, respectively. General clinical data, National Institutes of Health Stroke Scale score, modified Rankin Scale score, post-thrombolytic bleeding events, and blood lipids were compared between the two groups. Results: The teneplase group had a greater reduction in post-treatment NIHSS score, 90 d mRS score, and a lower incidence of oral mucosal bleeding compared with the alteplase group. Conclusion: Teneplase combined with atorvastatin calcium is clinically more effective and safe compared with alteplase in the treatment of patients with acute ischemic stroke.
| [1] | Mendelson, S.J. and Prabhakaran, S. (2021) Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke. JAMA, 325, 1088-1098. https://doi.org/10.1001/jama.2020.26867 |
| [2] | Hilkens, N.A., Casolla, B., Leung, T.W. and de Leeuw, F. (2024) Stroke. The Lancet, 403, 2820-2836. https://doi.org/10.1016/s0140-6736(24)00642-1 |
| [3] | Tu, W.-J., Wang, L.-D. and on Behalf of the Special Writing Group of China Stroke Surveillance Report (2023) China Stroke Surveillance Report 2021. Military Medical Research, 10, Article No. 33. https://doi.org/10.1186/s40779-023-00463-x |
| [4] | Ekker, M.S., Verhoeven, J.I., Vaartjes, I., van Nieuwenhuizen, K.M., Klijn, C.J.M. and de Leeuw, F. (2019) Stroke Incidence in Young Adults according to Age, Subtype, Sex, and Time Trends. Neurology, 92, e2444-e2454. https://doi.org/10.1212/wnl.0000000000007533 |
| [5] | 陈红芳, 张美霞, 潘小玲. 急性缺血性卒中静脉溶栓治疗研究进展[J]. 心电与循环, 2024, 43(5): 437-444. |
| [6] | Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A.C., Padiglioni, C., et al. (2021) European Stroke Organisation (ESO) Guidelines on Intravenous Thrombolysis for Acute Ischaemic Stroke. European Stroke Journal, 6, I-LXII. https://doi.org/10.1177/2396987321989865 |
| [7] | Yaghi, S., Eisenberger, A. and Willey, J.Z. (2014) Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke after Thrombolysis with Intravenous Recombinant Tissue Plasminogen Activator: A Review of Natural History and Treatment. JAMA Neurology, 71, 1181-1185. https://doi.org/10.1001/jamaneurol.2014.1210 |
| [8] | Miller, S.E. and Warach, S.J. (2023) Evolving Thrombolytics: From Alteplase to Tenecteplase. Neurotherapeutics, 20, 664-678. https://doi.org/10.1007/s13311-023-01391-3 |
| [9] | Koh, J.H., Lim, C.Y.J., Tan, L.T.P., Sia, C., Poh, K.K., Sharma, V.K., et al. (2024) Ethnic Differences in the Safety and Efficacy of Tenecteplase versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Journal of Stroke, 26, 371-390. https://doi.org/10.5853/jos.2024.01284 |
| [10] | 高萍萍. 阿替普酶联合阿托伐他汀治疗急性脑梗死效果观察[J]. 大医生, 2023, 8(4): 61-63. |
| [11] | 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682. |
| [12] | Sato, S., Toyoda, K., Uehara, T., Toratani, N., Yokota, C., Moriwaki, H., et al. (2008) Baseline NIH Stroke Scale Score Predicting Outcome in Anterior and Posterior Circulation Strokes. Neurology, 70, 2371-2377. https://doi.org/10.1212/01.wnl.0000304346.14354.0b |
| [13] | Nimbvikar, A.A., Panchawagh, S., Chavan, A.P., Ingole, J.R., Pargaonkar, Y. and Pai, R. (2024) Modified Rankin Scale Is a Reliable Tool for the Rapid Assessment of Stroke Severity and Predicting Disability Outcomes. Journal of Family Medicine and Primary Care, 13, 1085-1090. https://doi.org/10.4103/jfmpc.jfmpc_1431_23 |
| [14] | Keyt, B.A., Paoni, N.F., Refino, C.J., Berleau, L., Nguyen, H., Chow, A., et al. (1994) A Faster-Acting and More Potent Form of Tissue Plasminogen Activator.. Proceedings of the National Academy of Sciences, 91, 3670-3674. https://doi.org/10.1073/pnas.91.9.3670 |
| [15] | 陈会生, 杨清武, 程忻. 急性缺血性卒中替奈普酶静脉溶栓治疗中国专家共识[J]. 中国神经精神疾病杂志, 2022, 48(11): 641-651. |
| [16] | 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性卒中诊治指南2023 [J]. 中华神经科杂志, 2024, 57(6): 523-559. |
| [17] | Meng, X., Li, S., Dai, H., Lu, G., Wang, W., Che, F., et al. (2024) Tenecteplase vs Alteplase for Patients with Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial. JAMA, 332, 1437-1445. https://doi.org/10.1001/jama.2024.14721 |
| [18] | Zhang, X., Wan, T., Chen, J. and Liu, L. (2023) Tenecteplase versus Alteplase for Patients with Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. Aging, 15, 14889-14899. https://doi.org/10.18632/aging.205315 |
| [19] | Parsons, M., Spratt, N., Bivard, A., Campbell, B., Chung, K., Miteff, F., et al. (2012) A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke. New England Journal of Medicine, 366, 1099-1107. https://doi.org/10.1056/nejmoa1109842 |
| [20] | Huang, X., Cheripelli, B.K., Lloyd, S.M., Kalladka, D., Moreton, F.C., Siddiqui, A., et al. (2015) Alteplase versus Tenecteplase for Thrombolysis after Ischaemic Stroke (ATTEST): A Phase 2, Randomised, Open-Label, Blinded Endpoint Study. The Lancet Neurology, 14, 368-376. https://doi.org/10.1016/s1474-4422(15)70017-7 |
| [21] | Haley, E.C., Lyden, P.D., Johnston, K.C. and Hemmen, T.M. (2005) A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke. Stroke, 36, 607-612. https://doi.org/10.1161/01.str.0000154872.73240.e9 |
| [22] | Huang, X., Moreton, F.C., Kalladka, D., Cheripelli, B.K., MacIsaac, R., Tait, R.C., et al. (2015) Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke. Stroke, 46, 3543-3546. https://doi.org/10.1161/strokeaha.115.011290 |
| [23] | 李胜愉, 杨盛贤, 曾爱苹, 等. 大剂量阿托伐他汀联合阿替普酶对急性脑梗死患者血清炎症因子及神经功能的影响[J]. 中国医院用药评价与分析, 2021, 21(7): 816-819, 825. |
